ConnectiCare updates our policies regularly. Updates have been made to the following reimbursement policies and prior authorization lists for our commercial (employer group) members. See the revision histories for changes and their effective dates.
Reimbursement policies:
- Ambulatory Surgical Groupers
Lab Benefit Management (LBM) reimbursement policies:
- Biomarkers for Myocardial Infarction and Chronic Heart Failure (LBM)
- Colorectal Cancer (LBM)
- Coronavirus Testing in the Outpatient Setting (LBM)
- Diabetes Mellitus Testing (LBM)
- Gamma-Glutamyl Transferase (LBM)
- General Inflammation Testing (LBM)
- Identification of Microorganisms Using Nucleic Acid Probes (LBM)
- Oral Cancer Screening and Testing (LBM)
- Pathogen Panel Testing (LBM)
- Prenatal Screening (Nongenetic) (LBM)
- Serum Testing for Evidence of Mild Traumatic Brain Injury (LBM)
- Testing for Alpha-1 Antitrypsin Deficiency (LBM)
- Urine Culture Testing for Bacteria (LBM)
Prior authorization lists:
- ConnectiCare Prior Authorization Requirements (Commercial)
